Dual-pathway blockade therapy offers hope for rare, hard-to-treat gynecological clear cell cancers

Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a troubling mix of symptoms comprising extreme fatigue, chronic sinusitis, and appetite changes including a sudden aversion to foods such as chocolate and alcohol. Detailed tes